DYNE THERAPEUTICS INC. - COMMON STOCK
29.68
25-11月-24 11:43:11
15 分の遅延
株式
-0.01
-0.03%
本日の幅
29.19 - 30.77
ISIN
N/A
ソース
NASDAQ
-
Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
12 11 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Upcoming Investor Conferences
07 11 2024 15:15:00 提供 Nasdaq GlobeNewswire
-
09 10 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines Conference
23 9 2024 07:56:28 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Key Leadership Appointments
03 9 2024 05:31:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
29 8 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
12 8 2024 16:10:00 提供 Nasdaq GlobeNewswire
-
24 6 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
13 6 2024 15:40:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Global Healthcare Conference
30 5 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
28 5 2024 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Pricing of $325.5 Million Public Offering of Common Stock
21 5 2024 19:39:57 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Proposed Public Offering of Common Stock
20 5 2024 15:01:00 提供 Nasdaq GlobeNewswire
-
19 5 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
02 5 2024 15:10:00 提供 Nasdaq GlobeNewswire
-
27 3 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the Cantor Virtual Muscular Dystrophy Symposium
27 3 2024 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces CEO Transition
25 3 2024 06:30:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >